The founders behind FY2026's biggest healthtech raises
Twenty companies took the bulk of Australian and New Zealand healthtech capital in FY2026. We know the deals. We rarely look at the people who raised them. So we pulled the founders of the top 20 by capital raised, stripped out the ASX listing, kept the genuine venture rounds and acquisitions, and asked a simple question. Who are they?
The first pattern is a confronting one. The money skews male, and it skews hardest at the top. The eight largest raises went almost entirely to all-male founding teams. Eucalyptus, HotDoc, 4DMedical, Heidi, Everlab, Splose, MedAdvisor, Dentroid. Women appear as you move down the table, not up it. Grace Brown at Andromeda. Georgia Vidler and Kate Lambridis at Human, an all-female team. Sarah McDonald at Oli. Kath Giles and Christobel Saunders at OncoRes. Pia Clinton-Tarestad at Clean Slate. The bigger the cheque, the less likely a woman signed for it. That tracks the national number. Teams with at least one female founder took roughly 15 per cent of private capital in 2024.
Look past sex and two founder types dominate:
The clinician who got tired of the system.
The engineer who found a problem worth a decade.
Dr Ben Hurst left medicine to build HotDoc. Dr Tom Kelly walked out of vascular surgery to start Heidi. Omar Zuaiter was a dentist before Dentroid. Sarah McDonald engineered her way out of a traumatic birth. On the other side sit the deep tech spin-outs. Andreas Fouras and 4DMedical came out of Monash. Omniscient, OncoRes, Kitea, Nutromics and AlleSense were all born in a university lab.
Then there is a third seam, and it is the one investors love
The consumer operator who crossed into health.
Tim Doyle built Eucalyptus off the back of Koala. Vidler and Lambridis came from Canva. Everlab pulled talent from Airwallex, Goldman and a German brand sold to Mars. These founders did not train in medicine. They trained in growth, and they brought it with them.
Geography is less of a surprise and more of a reminder. Melbourne leads, just, Sydney follows. But Perth built OncoRes, Adelaide built Splose, Canberra built Dentroid, and Auckland built Kitea. The talent is not always where you think it is.
One last thread worth naming is migration. Zuaiter from Pakistan and Jordan. His co-founder Alaa Habeb from Syria. Marc Hermann from Germany. Michael Sughrue from the United States. Stephane Doyen from France. Some of the most ambitious health technology in this country was built by people who chose to be here.
So what does the FY2026 cohort tell us? That capital still flows to a narrow profile at the top, that clinicians and engineers remain the engine, and that the operators crossing in from consumer tech are quietly winning the largest rounds. The names change every year. The patterns, so far, do not.
Healthtech startup looking to save years of intelligence gathering? Book in with us at Clinical Advisors here.
